Multiple-Ascending-Dose Study to Evaluate the Safety of Propoxyphene Napsylate In Healthy Adult Subjects

NCT01133873 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Propoxyphene napsylate (XP20C)
DRUG: Placebo

Sponsor

Xanodyne Pharmaceuticals